Last 47 quarters of trend data · Healthcare · Medical Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -4.56 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 146.19 | 135.86 | 385.36 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/B Ratio | 0.66 | 1.90 | 2.18 | 1.73 | 1.88 | 3.03 | 0.89 | 5.40 | 3.87 | 2.50 | 2.80 | 4.42 | 2.21 | 2.64 | 3.44 | 3.19 | 6.14 | 4.27 | 3.84 | 3.71 | 2.80 |
| — | -37.3% | +146.0% | -67.9% | -51.5% | +21.1% | -68.3% | +22.2% | +74.8% | -5.4% | -18.5% | +38.7% | -64.0% | -38.1% | -10.4% | -14.0% | +119.6% | +52.2% | +41.6% | +83.9% | +36.4% | |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | — | -266.8% | 1.9% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Operating Margin | — | -2567.6% | -4114.3% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Net Margin | — | -2334.9% | -3496.2% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -32.4% | -7.9% | -4.8% | -4.4% | -6.6% | -11.8% | -16.0% | -92.5% | -65.2% | -40.3% | -44.5% | -53.2% | -29.1% | -32.0% | -47.0% | -46.8% | -49.3% | -34.8% | -24.5% | -23.9% | -13.5% |
| — | +33.3% | +69.8% | +95.2% | +89.9% | +70.7% | +64.0% | -73.8% | -124.2% | -26.2% | +5.5% | -13.7% | +41.0% | +8.3% | -91.7% | -95.4% | -266.4% | -194.6% | -139.5% | -130.4% | -49.3% | |
| ROA | -30.0% | -7.4% | -4.6% | -4.2% | -6.2% | -10.9% | -14.1% | -60.4% | -50.9% | -33.3% | -30.2% | -36.6% | -24.7% | -26.8% | -36.2% | -35.4% | -38.6% | -29.0% | -20.9% | -21.2% | -12.3% |
| — | +32.0% | +67.3% | +93.0% | +87.8% | +67.2% | +53.4% | -64.7% | -105.6% | -24.5% | +16.6% | -3.6% | +36.0% | +7.7% | -73.0% | -67.2% | -214.3% | -165.9% | -121.3% | -117.9% | -44.1% | |
| ROIC | -29.5% | -6.7% | -4.4% | -4.2% | -5.9% | -10.7% | -17.2% | -130.3% | -69.1% | -42.1% | -47.8% | -36.4% | -36.9% | -48.7% | -52.6% | -66.3% | -147.9% | -145.6% | -139.3% | -88.0% | -37.0% |
| — | +37.0% | +74.1% | +96.8% | +91.5% | +74.6% | +64.1% | -258.3% | -87.2% | +13.6% | +9.1% | +45.2% | +75.0% | +66.5% | +62.2% | +24.6% | -299.9% | -305.9% | -312.2% | -39.1% | +81.9% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.03 | 0.02 | 0.02 | 0.03 | 0.05 | 0.03 | 0.03 | 0.08 | 0.06 | 0.09 | 0.07 | 0.06 | 0.05 | 0.04 |
| — | +158.9% | +154.2% | -64.5% | -53.4% | -79.9% | -85.9% | -38.7% | -25.9% | -27.0% | -58.4% | -19.0% | -63.4% | -50.1% | +34.2% | +34.0% | +131.5% | +90.7% | +82.8% | +41.4% | +28.1% | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 23.33 | 18.56 | 22.59 | 23.33 | 27.53 | 12.06 | 16.19 | 2.37 | 3.64 | 5.32 | 5.92 | 2.09 | 5.64 | 7.81 | 4.53 | 4.26 | 4.00 | 5.60 | 7.61 | 8.00 | 13.47 |
| — | +53.9% | +39.5% | +886.4% | +655.7% | +126.6% | +173.7% | +13.1% | -35.4% | -31.8% | +30.7% | -50.9% | +40.9% | +39.5% | -40.5% | -46.8% | -70.3% | -67.9% | -58.2% | -57.4% | -54.1% | |
| Quick Ratio | 23.16 | 17.82 | 21.93 | 23.16 | 27.53 | 12.06 | 16.19 | 2.37 | 3.64 | 5.32 | 5.92 | 2.09 | 5.64 | 7.81 | 4.53 | 4.26 | 4.00 | 5.60 | 7.61 | 8.00 | 13.47 |
| — | +47.7% | +35.4% | +879.2% | +655.7% | +126.6% | +173.7% | +13.1% | -35.4% | -31.8% | +30.7% | -50.9% | +40.9% | +39.5% | -40.5% | -46.8% | -70.3% | -67.9% | -58.2% | -57.4% | -54.1% | |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -244.31 | — | -850.67 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying MBOT stock.
Microbot Medical Inc.'s current P/E is -4.6x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Microbot Medical Inc.'s business trajectory between earnings reports.